MINISO Group Holding Ltd (MNSO) Stock Price Today
Aura AI Summary
Key Stats
- $3.19BMarket Cap
- -Volume
- TechnologySector
- $26.6352W High
- $10.6852W Low
- -Typical Hold Time
- $3.87BEnterprise Value
- 6.24%Div Yield
- -Trading Activity
Track MINISO Group Holding Ltd (MNSO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, MINISO Group Holding Ltd has traded between a low of $10.68 and a high of $26.63, highlighting its annual price range. Buy and sell MINISO Group Holding Ltd shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About MINISO Group Holding Ltd
MINISO Group Holding Ltd is a global lifestyle product retailer known for its aesthetically pleasing, high-quality, and low-cost goods. The company operates a network of branded stores worldwide, offering a diverse range of merchandise, including household goods, cosmetics, toys, and digital accessories. MINISO's business model emphasizes rapid product iteration, efficient supply chain management, and a joint venture and franchise partner network to facilitate its global expansion.
Most Recent News
Ark Invest buys $27M Nvidia and $16M Broadcom amid market sell-off, signaling potential buying opportunity.
During the recent market sell-off, Cathie Wood's Ark Invest purchased $27 million worth of Nvidia shares and $16 million of Broadcom shares. These significant buys by a well-known investor suggest confidence in these tech stocks despite broader marke...

Director Carande buys 2,101 shares of United Community Banks, signaling confidence.
Director Carande has purchased 2,101 shares of United Community Banks. This insider buying may indicate confidence in the company's future prospects. Investors often view such transactions as a positive signal, potentially influencing market sentimen...

Bio-Techne Q4 revenue beats estimates; Merck KGaA acquisition keeps stock near $73 offer price.
Bio-Techne reported Q4 revenues of $321.2 million, slightly surpassing estimates, but its adjusted EPS fell 1.9% year-over-year to $0.52, showing mixed financial results. The company's stock remains close to Merck KGaA's $73 per share acquisition off...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.